AlaskOmega (Omega-3 Fish Oil Concentrate) — Hermetica Encyclopedia
Branded Ingredients · Other

AlaskOmega (Omega-3 Fish Oil Concentrate)

Preliminary EvidenceCompound

Hermetica Superfood Encyclopedia

The Short Answer

AlaskOmega is a concentrated omega-3 fish oil ingredient standardized to deliver at least 650 mg of EPA and DHA per gram, sourced from Alaskan pollock. These long-chain polyunsaturated fatty acids reduce triglycerides, modulate inflammatory signaling, and support cardiovascular function through well-characterized lipid metabolism pathways.

PubMed Studies
0
Validated Benefits
Synergy Pairings
At a Glance
CategoryBranded Ingredients
GroupOther
Evidence LevelPreliminary
Primary KeywordAlaskOmega fish oil supplement
AlaskOmega close-up macro showing natural texture and detail — rich in epa and dha exert pleiotropic pharmacological effects via multiple mechanisms: (1) eicosanoid pathway modulation — competitive inhibition of cox-1/cox-2 and 5-lox enzymes, reducing synthesis of pro-inflammatory thromboxane a2 (txa2) and leukotriene b4 while favoring production of less potent 3-series thromboxanes and 5-series leukotrienes, plus generation of pro-resolving mediators (resolvins
AlaskOmega (Omega-3 Fish Oil Concentrate) — botanical close-up

Health Benefits

Origin & History

AlaskOmega growing in natural environment — natural habitat
Natural habitat

AlaskOmega is a branded omega-3 fish oil concentrate derived from wild-caught Alaska Pollock (Gadus chalcogrammus) from the Bering Sea. The oil is extracted by heating fish remains after roe and fillet removal, then purified and concentrated via molecular distillation, ethyl esterification, and multi-step filtration to achieve up to 85% total omega-3 concentration.

No information on historical or traditional medicine use is provided in the research. AlaskOmega is described as a modern branded concentrate from wild Alaska Pollock with no documented ties to traditional systems.Traditional Medicine

Scientific Research

No specific human clinical trials, RCTs, or meta-analyses on AlaskOmega itself are provided in the research dossier. The manufacturer references general EPA and DHA research but does not cite AlaskOmega-specific trials or provide PMIDs.

Preparation & Dosage

AlaskOmega traditionally prepared — pairs with Vitamin E, CoQ10, Astaxanthin
Traditional preparation

No clinically studied dosage ranges for AlaskOmega are detailed in the research. Products provide ≥650 mg/g total EPA+DHA with concentrations up to 85% total omega-3s in ethyl ester or re-esterified triglyceride forms. Consult a healthcare provider before starting any new supplement.

Nutritional Profile

AlaskOmega is a highly concentrated omega-3 fish oil delivering ≥650 mg/g total EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) combined, sourced from wild Alaskan pollock. Typical concentration yields approximately 360–400 mg/g EPA and 240–280 mg/g DHA, though exact EPA:DHA ratio varies by product specification. The oil is delivered primarily in triglyceride (TG) form, which research suggests offers superior bioavailability compared to ethyl ester (EE) forms — studies indicate triglyceride-form omega-3s are absorbed approximately 50% more efficiently than ethyl esters when taken with food. Caloric contribution is approximately 9 kcal per gram of oil (fat-based). Contains negligible protein, carbohydrates, and fiber. Minor fat-soluble components may include naturally occurring vitamin E (tocopherols) added as an antioxidant to stabilize the oil and prevent oxidation, typically at low preservative doses (1–10 mg/g range). The purification process (molecular distillation or equivalent) removes environmental contaminants including PCBs, dioxins, furans, and heavy metals (mercury, lead, cadmium, arsenic) to below detectable or regulatory limits. Low oxidation status is maintained with TOTOX values controlled during manufacturing, preserving oil integrity and reducing pro-inflammatory oxidized lipid byproducts. No significant micronutrient content (vitamins A, D, K or minerals) is documented at therapeutic concentrations in this concentrate form.

How It Works

Mechanism of Action

EPA and DHA are incorporated into phospholipid membranes where they compete with arachidonic acid for cyclooxygenase and lipoxygenase enzymes, reducing synthesis of pro-inflammatory eicosanoids such as thromboxane A2 and leukotriene B4. EPA acts as a substrate for the production of specialized pro-resolving mediators including resolvins and protectins, which actively resolve inflammatory cascades. DHA activates PPARγ nuclear receptors and suppresses NF-κB signaling, contributing to reduced triglyceride synthesis in hepatocytes and improved endothelial nitric oxide bioavailability.

Clinical Evidence

No clinical trials have been conducted specifically on AlaskOmega as a branded ingredient; its efficacy is inferred from the broader body of EPA and DHA research, which the manufacturer cites as exceeding 40,000 published studies. Landmark trials such as REDUCE-IT (n=8,179) demonstrated that high-dose EPA (4 g/day icosapentaenoic acid ethyl ester) reduced major cardiovascular events by 25% in high-risk patients, while STRENGTH (n=13,078) using a DHA-containing formulation showed no significant benefit, highlighting that outcomes may depend on specific formulation and EPA-to-DHA ratio. Meta-analyses of general omega-3 supplementation consistently show reductions in serum triglycerides of 15–30% at doses of 2–4 g EPA+DHA per day. Because AlaskOmega delivers its EPA and DHA in concentrated triglyceride or re-esterified triglyceride form—formats used in clinical research—bioavailability is considered favorable, but direct comparative data for this specific ingredient remain unpublished.

Safety & Interactions

AlaskOmega-derived EPA and DHA are generally recognized as safe at doses up to 3 g/day per FDA guidelines, with higher doses used under medical supervision. The most common side effects are gastrointestinal, including fishy aftertaste, nausea, and loose stools, which can be minimized by taking capsules with meals. At doses above 3 g/day, EPA and DHA exhibit mild antiplatelet activity and may potentiate the effects of anticoagulants such as warfarin and antiplatelet drugs like clopidogrel, warranting INR monitoring. Omega-3 fish oil supplementation is considered safe during pregnancy and lactation to support fetal neurodevelopment, though individuals with fish or shellfish allergies should consult a physician before use.

Synergy Stack

Hermetica Formulation Heuristic

Also Known As

Alaska Pollock OilGadus chalcogrammus oilConcentrated Fish Oil from Alaska PollockBering Sea Fish Oil ConcentratePurified Alaska Pollock Omega-3Molecular Distilled Pollock Oil

Frequently Asked Questions

What is AlaskOmega and how is it different from regular fish oil?
AlaskOmega is a concentrated omega-3 ingredient sourced from wild Alaskan pollock, standardized to contain at least 650 mg of combined EPA and DHA per gram—roughly double the concentration found in standard fish oil, which typically delivers 300–330 mg/g. This higher concentration means consumers can achieve target EPA and DHA doses with fewer or smaller capsules. The use of a single, traceable Alaskan species also allows for tighter quality and sustainability controls compared to mixed-source fish oil products.
How much EPA and DHA does AlaskOmega provide per serving?
AlaskOmega is standardized to a minimum of 650 mg total omega-3s (EPA plus DHA) per gram of oil, meaning a 1-gram softgel can deliver at least 650 mg of combined EPA and DHA. The exact EPA-to-DHA ratio varies by specific product formulation, so consumers should check the supplement facts panel of the finished product. Clinical cardiovascular benefits for triglyceride reduction have been demonstrated at combined EPA+DHA doses of 2–4 g per day.
Does AlaskOmega lower triglycerides?
AlaskOmega itself has not been tested in dedicated clinical trials, but its active components—EPA and DHA—have extensive evidence supporting triglyceride reduction of 15–30% at doses of 2–4 g/day, primarily through suppression of hepatic VLDL-triglyceride synthesis via PPAR-α activation and downregulation of SREBP-1c. The FDA has approved prescription omega-3 formulations (icosapentaenoic acid and DHA ethyl esters) specifically for hypertriglyceridemia. Because AlaskOmega delivers its omega-3s in a highly concentrated form consistent with research-grade formulations, it is expected to confer similar benefits when dosed equivalently.
Is AlaskOmega fish oil safe to take with blood thinners?
At doses above 3 g/day of EPA and DHA, fish oil inhibits platelet aggregation by reducing thromboxane A2 production, which can enhance the anticoagulant effect of drugs such as warfarin (Coumadin), aspirin, and clopidogrel (Plavix). Patients on anticoagulant or antiplatelet therapy should inform their physician before adding high-dose omega-3 supplements, as INR levels may need monitoring. At commonly recommended dietary supplement doses of 1–2 g/day, clinically significant bleeding interactions are rare but not impossible, particularly in individuals taking multiple blood-thinning agents.
Where does AlaskOmega fish oil come from and is it sustainably sourced?
AlaskOmega is derived exclusively from Alaskan pollock (Gadus chalcogrammus), one of the world's most abundant and well-managed wild fish species, harvested in the Bering Sea under U.S. federal fishery management. Alaskan pollock fisheries are certified by the Marine Stewardship Council (MSC) and regulated under the Magnuson-Stevens Fishery Conservation and Management Act, making this one of the more traceable and sustainability-verified omega-3 sources available commercially. The single-species sourcing also reduces the risk of heavy metal contamination variability compared to multi-species fish oil blends.
How does AlaskOmega's concentration level compare to standard fish oil supplements?
AlaskOmega is a concentrated fish oil providing ≥650 mg/g of combined EPA and DHA, which is significantly higher than standard fish oil supplements that typically contain 300–500 mg/g total omega-3s. This higher concentration means you can achieve therapeutic EPA and DHA levels with fewer capsules, improving convenience and compliance. The concentration process also allows the manufacturer to remove more contaminants like PCBs, dioxins, and heavy metals per serving.
Is AlaskOmega appropriate for people with shellfish allergies?
AlaskOmega is derived from fish, not shellfish, so it may be suitable for those with shellfish allergies; however, cross-contamination during processing is possible depending on facility practices. Individuals with fish allergies should avoid AlaskOmega entirely. Those with shellfish allergies should consult the manufacturer's documentation about facility protocols before use, and consult their healthcare provider if unsure.
What quality control measures does AlaskOmega use to prevent oxidation and rancidity?
AlaskOmega employs processing techniques to maintain low oxidation levels, which helps preserve the stability and efficacy of EPA and DHA during storage. The ingredient also undergoes contaminant removal for PCBs, dioxins, and heavy metals, which can accelerate oxidative degradation. Proper storage in a cool, dark place away from heat and light further protects the product from oxidative damage after purchase.

Explore the Full Encyclopedia

7,400+ ingredients researched, verified, and formulated for optimal synergy.

Browse Ingredients
These statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.